✅ The verified answer to this question is available below. Our community-reviewed solutions help you understand the material better.
Patient D was diagnosed with a mild to moderate form of Alzheimer’s Disease in 2016.
However, their cognitive state has recently deteriorated and they have been prescribed an NMDA receptor antagonist (memantine), which: